<?xml version="1.0" encoding="UTF-8"?>
<document id="29309627">
	<sentence id="s1" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.">
		<entity id="s1.e1" charOffset="48-54"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="56-67"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<entity id="s1.e3" charOffset="207-212"
			type="GENE" text="HLXB9" ontology_id="3110"/>
		<entity id="s1.e4" charOffset="233-237"
			type="GENE" text="NONO" ontology_id="4841"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p3" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p4" e1="s1.e5"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Also, two somatic heterozygous NONO mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
		<entity id="s2.e1" charOffset="31-35"
			type="GENE" text="NONO" ontology_id="4841"/>
		<entity id="s2.e2" charOffset="78-84"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="152-157"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Overall, our results highlight the importance of HLXB9 in conditions of β-cell excess (insulinomas) and in conditions of β-cell loss or dysfunction (diabetes).">
		<entity id="s3.e1" charOffset="49-54"
			type="GENE" text="HLXB9" ontology_id="3110"/>
		<entity id="s3.e2" charOffset="87-98"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Our studies implicate therapeutic strategies for either reducing β-cell proliferation in insulinomas or alleviating normal β-cell deficiency in diabetes through the modulation of HLXB9 phosphorylation">
		<entity id="s4.e1" charOffset="89-100"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<entity id="s4.e2" charOffset="179-184"
			type="GENE" text="HLXB9" ontology_id="3110"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
</document>
